Presentations
|
|
|
| |
Recombinant and Urinary Gonadotropins: Comparison of Efficacy, Safety and Consistency
|
|
| |
|
|
|
|
|
| |
Human Menopausal Gonadotropin Supplied
Luteinizing Hormone Activity - Helpful, Harmful or
Necessary?
|
|
| |
|
|
|
|
|
|
|
presentations from prior meetings:
|
|
| |
A Markov Model of the Cost Effectiveness
of Human-Derived FSH versus Recombinant FSH Using Comparative
Clinical Trial Data
|
|
| |
presented by Hind Hatoum, PhD
|
|
|
|
| |
Improving the efficacy, safety, cost-effectiveness
and acceptability of gonadotropin administration prior to
in vitro fertilization
|
|
| |
presented by William Keye, MD
view the presentation or read
the presentation transcript
|
|
|
